These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25104797)

  • 1. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism in obese, nondiabetic humans.
    Padilla N; Maraninchi M; Béliard S; Berthet B; Nogueira JP; Wolff E; Nicolay A; Bégu A; Dubois N; Grangeot R; Mattei C; Vialettes B; Xiao C; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2330-7. PubMed ID: 25104797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.
    Dash S; Xiao C; Morgantini C; Szeto L; Lewis GF
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2895-901. PubMed ID: 24072699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes.
    Nogueira JP; Maraninchi M; Béliard S; Padilla N; Duvillard L; Mancini J; Nicolay A; Xiao C; Vialettes B; Lewis GF; Valéro R
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1039-44. PubMed ID: 22308041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-relationships between proprotein convertase subtilisin/kexin type 9, apolipoprotein C-III and plasma apolipoprotein B-48 transport in obese subjects: a stable isotope study in the postprandial state.
    Chan DC; Wong AT; Pang J; Barrett PH; Watts GF
    Clin Sci (Lond); 2015 Mar; 128(6):379-85. PubMed ID: 25291660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M; Padilla N; Béliard S; Berthet B; Nogueira JP; Dupont-Roussel J; Mancini J; Bégu-Le Corroller A; Dubois N; Grangeot R; Mattei C; Monclar M; Calabrese A; Guérin C; Desmarchelier C; Nicolay A; Xiao C; Borel P; Lewis GF; Valéro R
    J Clin Lipidol; 2017; 11(2):495-506.e3. PubMed ID: 28502507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bariatric surgery on hepatic and intestinal lipoprotein particle metabolism.
    Dash S; Xiao C; Lewis GF
    Curr Opin Lipidol; 2016 Feb; 27(1):14-8. PubMed ID: 26628436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production.
    Duez H; Lamarche B; Uffelman KD; Valéro R; Szeto L; Lemieux S; Cohn JS; Lewis GF
    J Clin Endocrinol Metab; 2008 May; 93(5):1722-9. PubMed ID: 18285418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism.
    Chan DC; Watts GF; Somaratne R; Wasserman SM; Scott R; Barrett PHR
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1644-1655. PubMed ID: 29880491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of growth hormone in hepatic and intestinal triglyceride-rich lipoprotein metabolism.
    Maraninchi M; Calabrese A; Nogueira JP; Castinetti F; Mancini J; Mourre F; Piétri L; Bénamo E; Albarel F; Morange I; Dupont-Roussel J; Nicolay A; Brue T; Béliard S; Valéro R
    J Clin Lipidol; 2021; 15(5):712-723. PubMed ID: 34462238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men.
    Xiao C; Dash S; Stahel P; Lewis GF
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women.
    Mekki N; Christofilis MA; Charbonnier M; Atlan-Gepner C; Defoort C; Juhel C; Borel P; Portugal H; Pauli AM; Vialettes B; Lairon D
    J Clin Endocrinol Metab; 1999 Jan; 84(1):184-91. PubMed ID: 9920081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial lipemia associates with liver fat content.
    Matikainen N; Mänttäri S; Westerbacka J; Vehkavaara S; Lundbom N; Yki-Järvinen H; Taskinen MR
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3052-9. PubMed ID: 17488790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
    Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
    Hooper AJ; Robertson K; Barrett PH; Parhofer KG; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1474-8. PubMed ID: 17213276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans.
    Xiao C; Dash S; Morgantini C; Lewis GF
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1457-63. PubMed ID: 27150393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-2 regulates release of chylomicrons from the intestine.
    Dash S; Xiao C; Morgantini C; Connelly PW; Patterson BW; Lewis GF
    Gastroenterology; 2014 Dec; 147(6):1275-1284.e4. PubMed ID: 25173752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans.
    Duez H; Lamarche B; Uffelman KD; Valero R; Cohn JS; Lewis GF
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1357-63. PubMed ID: 16614317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.